This bill proposes to amend the Federal Food, Drug, and Cosmetic Act to expand the definition of a "practitioner" eligible to prescribe drugs. It clarifies that artificial intelligence and machine learning technologies can qualify as such practitioners, provided they meet specific criteria. For these technologies to prescribe drugs, they must first be authorized by a statute of the State involved . Furthermore, the AI/ML technology must be approved, cleared, or authorized by the Food and Drug Administration (FDA) under sections 510(k), 513, 515, or 564 of the Act. This legislation aims to integrate advanced technological solutions into the drug prescription process, ensuring both state authorization and federal regulatory oversight.